BioBridgeXAll companies

BiomeSense, Inc.

Biotechnology company · Chicago, Illinois, United States

BiomeSense, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $7.1 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

BiomeSense at a glance

Typebiotechnology company
HeadquartersChicago, Illinois, United States
Earliest incorporation on record2018
Employees (self-reported, 2025)7
SEC CIK1789915

What does BiomeSense do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1.4 million in total (2021 to 2025). NIH funding came from the National Center for Advancing Translational Sciences.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $7.1 million sold (2025).

Frequently asked questions about BiomeSense

Where is BiomeSense headquartered?

BiomeSense, Inc. is headquartered in Chicago, Illinois, United States.

What does BiomeSense do?

BiomeSense, Inc. is a biotechnology company.

When was BiomeSense founded?

The earliest incorporation on record for BiomeSense, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences